In summary, we have identified two mutations in UBA3 which were not previously reported or characterized and demonstrated that these mutations confer MLN4924 resistance in leukemia cell lines but do not impair normal function of the NAE enzyme and activity of the neddylation pathway. Here, UBA3 is linked to leukemia.